Jpmorgan Chase & CO Amgen Inc Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Amgen Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,526,561 shares of AMGN stock, worth $703 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

2,526,561

Previous 2,391,242 5.66%

Holding current value

$703 Million

Previous $747 Million 8.96%

% of portfolio

0.07%

Previous 0.07%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$309.38 - $337.38 $41.9 Million - $45.7 Million	135,319 Added 5.66%	2,526,561 $814 Million
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $310 Million - $377 Million	-1,180,192 Reduced 33.05%	2,391,242 $747 Million
Q1 2024 May 10, 2024	SELL	$268.87 - $324.56 $106 Million - $127 Million	-392,819 Reduced 9.91%	3,571,434 $1.02 Billion
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $273 Million - $308 Million	-1,067,496 Reduced 21.22%	3,964,253 $1.14 Billion
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $16.1 Million - $20 Million	-73,857 Reduced 1.45%	5,031,749 $1.35 Billion
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $194 Million - $229 Million	-903,164 Reduced 15.03%	5,105,606 $1.13 Billion
Q1 2023 May 18, 2023	BUY	$225.79 - $275.2 $56.7 Million - $69.2 Million	251,297 Added 4.36%	6,008,770 $1.45 Billion
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $546 Million - $665 Million	-2,417,451 Reduced 29.57%	5,757,473 $1.39 Billion
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $521 Million - $661 Million	2,272,995 Added 38.51%	8,174,924 $2.15 Billion
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $44.9 Million - $50.6 Million	-199,898 Reduced 3.28%	5,901,929 $1.33 Billion
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $113 Million - $126 Million	489,547 Added 8.72%	6,101,827 $1.48 Billion
Q1 2022 May 11, 2022	BUY	$219.27 - $242.57 $442 Million - $489 Million	2,017,567 Added 56.13%	5,612,280 $1.36 Billion
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $405,516 - $464,076	2,039 Added 0.06%	3,594,713 $809 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $763 Million - $893 Million	3,592,674 New	3,592,674 $764 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Amgen Inc Transaction History